Taribavirin
Taribavirin is an oral, liver-targeting inhibitor of inosine monophosphate dehydrogenase (IMPDH) developed for hepatitis C virus (HCV) research. Its design aims to minimize red blood cell distribution, thereby reducing the risk of hemolytic anemia in experimental models, making it a tool for studying antiviral mechanisms in vitro and in vivo.
Product Specifications
CAS Number
119567-79-2
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Smiles
O[C@H]1[C@@H] (O[C@H] (CO) [C@H]1O) N2N=C (C (=N) N) N=C2
Molecular Formula
C8H13N5O4
Molecular Weight
243.22
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
147499 100 µg
NCF1, Control Peptide (Neutrophil Cytosol Factor 1, NCF-1, 47kD Autosomal Chronic Granulomatous Disease Protein, 47kD Neutrophil Oxidase Factor, NCF-47K, Neutrophil NADPH Oxidase Factor 1, Nox Organizer 2, Nox-organizing Protein 2, SH3 and PX Domain-containing Protein 1A, p47-phox, NOXO2, SH3PXD1A)
Sign In for Pricing
View Details TRV-0028073 96 Tests
Multiplex Assay Kit for Pancreatic Lipase (PL), etc. by FLIA (Flow Luminescence Immunoassay)
Sign In for Pricing
View Details